{"nctId":"NCT00123955","briefTitle":"PIE II: Pharmacological Intervention in the Elderly II","startDateStruct":{"date":"2005-04"},"conditions":["Diastolic Heart Failure","Heart Failure, Congestive"],"count":80,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Spironolactone"]},{"label":"2","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Spironolactone","otherNames":["Aldactone"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Ambulatory\n* Medically stable\n* Ages 60 or older\n* Diagnosis of diastolic heart failure\n\nExclusion Criteria:\n\n* Valvular heart disease\n* Significant change in cardiac medication within the past 4 weeks\n* Uncontrolled hypertension\n* Recent or debilitating stroke\n* Cancer or other noncardiovascular conditions with life expectancy less than 2 years\n* Anemia\n* Elevated serum potassium\n* Renal insufficiency\n* Psychiatric disease (uncontrolled major psychoses, depression, dementia, or personality disorder)\n* Allergy to spironolactone; currently taking spironolactone or any aldosterone antagonist\n* Plans to leave area within 1 year\n* Refuses informed consent\n* Failure to pass screening tests: pulmonary function, echocardiogram, or exercise\n* Contra-indications to magnetic resonance imaging \\[MRI\\] (indwelling metal-containing prosthesis; pacemaker or defibrillator; history of welding occupation; uncontrollable claustrophobia)","healthyVolunteers":false,"sex":"ALL","minimumAge":"60 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Exercise Intolerance","description":"Peak exercise VO2","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.5","spread":"2.9"},{"groupId":"OG001","value":"13.3","spread":"2.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.6","spread":"3.5"},{"groupId":"OG001","value":"13.5","spread":"3.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.8","spread":"3.2"},{"groupId":"OG001","value":"13.9","spread":"3.7"}]}]}]},{"type":"PRIMARY","title":"Quality of Life Measured by the Minnesota Living With Heart Failure Questionnaire-total Score","description":"The Minnesota Living with Heart Failure Questionnaire (MLHF) is a self-administered disease-specific questionnaire for patients with Heart Failure, comprising 21 items rated on six-point Likert scales, representing different degrees of impact of HF on HRQoL, from 0 (none) to 5 (very much). It provides a total score (range 0-105, from best to worst HRQoL), as well as scores for two dimensions, physical (8 items, range 0-40) and emotional (5 items, range 0-25). The other eight items (of the total of 21) are only considered for the calculation of the total score.\n\nScale of 0-105:The higher the score the worse the heart failure related Quality of Life.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":"21"},{"groupId":"OG001","value":"28","spread":"19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29","spread":"20"},{"groupId":"OG001","value":"29","spread":"23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29","spread":"18"},{"groupId":"OG001","value":"25","spread":"18"}]}]}]},{"type":"SECONDARY","title":"Concentric Left Ventricular Remodeling","description":"Left ventricle measurements by MRI:\n\nMass/end diastolic volume ratio: g/ml","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":".4"},{"groupId":"OG001","value":"1.7","spread":".5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":".4"},{"groupId":"OG001","value":"1.6","spread":".4"}]}]}]},{"type":"SECONDARY","title":"Left Ventricular Diastolic Stiffness","description":"Echocardiography Doppler measurement of left ventricular diastolic function:\n\nEarly mitral annulus velocity (lateral) (Ea; cm/s)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.0","spread":"2.1"},{"groupId":"OG001","value":"6.8","spread":"1.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.0","spread":"2.1"},{"groupId":"OG001","value":"6.8","spread":"1.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.4","spread":"2.2"},{"groupId":"OG001","value":"6.6","spread":"1.6"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":42},"commonTop":[]}}}